High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.
about
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domainsReliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virusEntry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptorScavenger receptor BI and BII expression levels modulate hepatitis C virus infectivityInitiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type IClaudin-6 and claudin-9 function as additional coreceptors for hepatitis C virusTranscriptome analysis of a cnidarian-dinoflagellate mutualism reveals complex modulation of host gene expression.Roles of lipoprotein receptors in the entry of hepatitis C virusImpact of lipids and lipoproteins on hepatitis C virus infection and virus neutralizationAutophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesAn Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing AntibodiesBasic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered EntryHepatitis C Virus Entry Depends on Clathrin-Mediated EndocytosisA milestone for hepatitis C virus research: A virus generated in cell culture is fully viable in vivoCell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitroIdentification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 BindingA focus reduction neutralization assay for hepatitis C virus neutralizing antibodiesCD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus InfectionHigh-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density LipoproteinExpression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 BindingStudying Hepatitis C Virus: Making the Best of a Bad VirusScavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic CellsDissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 bindingCD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus EntryApolipoprotein C1 Association with Hepatitis C VirusIdentification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing AntibodiesAnalysis of a conserved RGE/RGD motif in HCV E2 in mediating entryResidues in a Highly Conserved Claudin-1 Motif Are Required for Hepatitis C Virus Entry and Mediate the Formation of Cell-Cell ContactsHepatitis C Virus entry: the early steps in the viral replication cycleMutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entryIdentification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C VirusRole of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular DeterminantsNovel concepts in HDL pharmacology.Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesRole for phospholipid acyl chains and cholesterol in pulmonary infections and inflammationNovel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell cultureHuman monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzeesNaturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralizationCell-cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors.
P2860
Q21089621-CC4A8B74-FFB6-455E-BE03-80D37B77A679Q21090530-839291ED-7CAD-417E-8E69-B99482173547Q24336433-303893E9-C33A-468C-91DC-4E355FB16E42Q24672232-D82A36CA-2CA7-49D8-8F90-B349408A6852Q24676039-A6B768C6-8DA2-46FB-87CE-A2A7FB1CD853Q24681592-27248F42-4ED4-4272-90D6-54249C11B263Q25255921-6816A2EB-178C-4730-AEBA-D3D264A93F4FQ26777338-0191CC18-30A4-4F93-9685-E6A2E93FE0F4Q26864485-CC45BF4B-B969-430B-A55D-32038B628CDFQ26992256-F332A960-FFBD-4260-B259-4B6ADF6CADE1Q27469837-9542F775-7655-490C-B62B-F928DF556788Q27472768-C73C3544-149E-4886-901C-7A5619EF82EDQ27472926-FBEF5BB1-F6A3-4B93-91EC-BA3DCB9000A1Q27473290-67CE0CD1-3218-41BA-AD21-67DDD415D6CAQ27473434-FD6162C6-A950-48E3-9869-F59831994AE8Q27473436-3AD8556B-1F48-4B75-B2CB-DEB82FCCEF24Q27477468-FACBE44D-B560-46A3-91A1-A1C782598809Q27478295-D86EA80D-E762-413A-8F3A-DADABECB808CQ27480351-B43E17B5-F6BC-467B-BE65-88A5402B233BQ27481010-8CE9F192-FBF6-4AFD-B943-186418421E0FQ27481026-CA347719-7C8B-4822-B7D5-63EB8C23FCD6Q27481034-81EDA253-AF7A-4CB4-8C45-B5FCD8BE4124Q27485559-621999DC-6F02-4BC2-8528-32246AB842F6Q27485638-5F443E1F-22B3-44CA-B6A4-75C3CBCCE04AQ27485899-08085F7E-1169-4932-874D-BE20B48C14D4Q27486923-0E88497A-0217-4CD1-9E3E-2D53EE59247DQ27487399-B23EB463-6F42-4036-9137-7AABB589EA8DQ27487872-3EA94554-6D6F-4C14-BA0A-5AF08BCC82A6Q27488396-9FCBF587-9777-4885-95A5-DBEC3CE2A127Q27489242-F3A08884-3DC6-40CA-BEB7-7E4041BFA2D5Q27489898-BFB72932-6BFD-4EBB-AB54-9EF3F10C7E54Q27490467-8C39B212-F38C-4D48-A0EB-1AE5ECAF78F3Q27490535-0FE6FAAB-A29A-4CC4-B7E6-377C36ECFF11Q27692691-16721D21-94A0-4835-8CF2-53D8D0E21112Q28081216-ED274BA8-B1B5-42C6-9BA5-0DF55ABCAD9EQ28391857-3157BA72-711F-43BF-A614-14DE52FD0AB4Q28482494-1FF50794-5E06-4AD4-8514-9B2CC7318AD2Q28483065-B145F87D-BDC2-4B74-8717-300D3B5B7FE1Q28731355-B149CCC3-BE84-4E50-B302-9BECCA3B085FQ30541731-3B5F78D1-BFE0-4994-93F7-5894C66BF656
P2860
High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
High density lipoproteins faci ...... enger receptor class B type I.
@en
type
label
High density lipoproteins faci ...... enger receptor class B type I.
@en
prefLabel
High density lipoproteins faci ...... enger receptor class B type I.
@en
P2093
P2860
P356
P1476
High density lipoproteins faci ...... enger receptor class B type I.
@en
P2093
Anne Op De Beeck
Cécile Voisset
Emmanuelle Blanchard
Ngoc Vu-Dac
P2860
P304
P356
10.1074/JBC.M411600200
P407
P577
2005-01-04T00:00:00Z